Eurotrol Hematocrit Control

FDA 510(k) K121467 · Eurotrol B.V.

Substantially Equivalent

510(k) numberK121467

Submission

Device name
Eurotrol Hematocrit Control
Applicant
Eurotrol B.V.
Ede, NL
Received
May 17, 2012
Decision date
May 10, 2013
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
GLK – Control, Hematocrit
Device class
Class II (moderate risk)
Regulation
21 CFR 864.8625
Specialty
Hematology

Other 510(k)s with product code GLK

510(k)DeviceApplicantDecision
K021924Medica Easyqc Hematocrit ControlGLK · Traditional Bionostics, Inc.06/24/2002SE
K020618Aalto Scientific Mirco Hematocrit ControlGLK · Traditional Aalto Scientific, Ltd.05/14/2002SE
K964452HematachekGLK · Traditional Richmond Diagnostics, Inc.02/20/1997SE
K961807Certain HCT Level a & Level B/Cvm HCT Levels 1,2,3, & 4GLK · Traditional Ciba Corning Diagnostics Corp.07/26/1996SE
K924926Msi-HctGLK · Traditional Medical Specialties, Inc.01/07/1993SE
K893562A.Qc HCT Level 1 and 2GLK · Traditional Johnson & Johnson Professionals, Inc.07/14/1989SE

More from Johnson & Johnson Professionals, Inc.

510(k)DeviceDecision
K192842HemoTrol Duo Low, HemoTrol Duo Normal, HemoTrol Duo HighGGM · Traditional 11/15/2019SE
K182744HemoTrol WB - Low, HemoTrol WB - Normal, HemoTrol WB - HighGGM · Traditional 02/01/2019SE
K152553CueSee HypoxicJJS · Traditional 04/22/2016SE
K131595Eurotrol Gas-Ise HCT QC and Eurotrol Gas-Ise HCT LVMJJY · Traditional 07/26/2013SE
K121468Eurotrol Gas-Ise MetabolitesJJY · Traditional 06/22/2012SE
K060215Albu Trol, Low, Model 108.001.002; Albu Trol, High 108.002.002JJX · Traditional 03/24/2006SE

Questions and answers

When was Eurotrol Hematocrit Control cleared by the FDA?

Eurotrol Hematocrit Control (K121467) received a 510(k) decision of Substantially Equivalent on May 10, 2013, 358 days after the submission was received.

What is the product code of K121467?

The FDA product code is GLK – Control, Hematocrit, a Class II (moderate risk) device regulated under 21 CFR 864.8625.